Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Gynecol Oncol. 2008 Nov 12;112(1):47–54. doi: 10.1016/j.ygyno.2008.09.043

Figure 1. Serum Biomarkers Significant Across Ovarian Epithelial Carcinoma Subtypes.

Figure 1

Findings presented in Table 3 are summarized. Listed biomarkers were found to differ significantly between comparison groups. Arrow preceding each biomarker name indicates increased or decreased serum concentrations in the cancer group. A. Comparison between benign cases and ovarian cancer subtypes. B. Comparison between clear cell, endometrial, and mucinous (CEM) carcinomas and serous carcinomas.